| Secondary |
| Product Used For Unknown Indication |
40.8% |
| Drug Use For Unknown Indication |
30.6% |
| Intentional Overdose |
20.4% |
| Insomnia |
3.1% |
| Anxiety |
2.0% |
| Gastrointestinal Disorder |
1.0% |
| Hypertension |
1.0% |
| Vertigo |
1.0% |
|
| Shock |
41.9% |
| Multi-organ Failure |
16.1% |
| Therapeutic Agent Toxicity |
9.7% |
| Intentional Overdose |
6.5% |
| Acute Respiratory Distress Syndrome |
3.2% |
| Blood Bilirubin Increased |
3.2% |
| Gingival Hyperplasia |
3.2% |
| Herpes Virus Infection |
3.2% |
| Overdose |
3.2% |
| Parkinsonism |
3.2% |
| Toxic Epidermal Necrolysis |
3.2% |
| Toxicity To Various Agents |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.9% |
| Drug Use For Unknown Indication |
16.0% |
| Multiple Sclerosis |
12.3% |
| Hypertension |
8.6% |
| Rheumatoid Arthritis |
4.6% |
| Pain |
4.1% |
| Diabetes Mellitus |
3.4% |
| Prophylaxis |
2.7% |
| Labyrinthitis |
2.6% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Hypercholesterolaemia |
2.3% |
| Osteoporosis |
2.0% |
| Dizziness |
1.9% |
| Osteoarthritis |
1.9% |
| Cardiac Disorder |
1.7% |
| Dysmenorrhoea |
1.7% |
| Gastric Disorder |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Radiotherapy |
1.4% |
| Epilepsy |
1.3% |
|
| Rhabdomyolysis |
13.0% |
| Aggression |
8.0% |
| Renal Impairment |
8.0% |
| Pulmonary Tuberculosis |
7.0% |
| Hypomagnesaemia |
6.0% |
| Left Ventricular Hypertrophy |
6.0% |
| Thrombocytopenia |
5.0% |
| Urinary Tract Infection |
5.0% |
| Weight Increased |
5.0% |
| Cerebral Infarction |
4.0% |
| Death |
4.0% |
| Organ Failure |
4.0% |
| Throat Tightness |
4.0% |
| Bone Pain |
3.0% |
| Cerebrovascular Accident |
3.0% |
| Lip Swelling |
3.0% |
| Pain In Extremity |
3.0% |
| Pyrexia |
3.0% |
| Renal Injury |
3.0% |
| Vertigo |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
100.0% |
|
| Toxicity To Various Agents |
100.0% |
|
